Comparative analysis of the JAK/STAT signaling through erythropoietin receptor and thrombopoietin receptor using a systems approach

BMC Bioinformatics

Volumn 10, Issue SUPPL. 1, 2009, Pages

  Won, Hong Hee ^a,b   Park, Inho ^a   Lee, Eunjung ^a,b   Kim, Jong Won ^c   Lee, Doheon ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE ANALYSIS; ERYTHROPOIETIN RECEPTORS; MODEL AND SIMULATION; MUTATION EFFECTS; MYELOPROLIFERATIVE DISORDERS; RECEPTOR KINETICS; SYSTEMS APPROACH; THROMBOPOIETIN RECEPTORS;

COMPUTER SIMULATION; KINETICS;

KINETICS; BIOINFORMATICS;

ERYTHROPOIETIN RECEPTOR; JANUS KINASE; STAT PROTEIN; THROMBOPOIETIN RECEPTOR;

ARTICLE; COMPARATIVE STUDY; COMPUTER SIMULATION; GENETICS; KINETICS; METABOLISM; MUTATION; MYELOPROLIFERATIVE DISORDER; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

COMPUTER SIMULATION; JANUS KINASES; KINETICS; MUTATION; MYELOPROLIFERATIVE DISORDERS; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, THROMBOPOIETIN; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SYSTEMS BIOLOGY;

EID: 60849121414     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-10-S1-S53     Document Type: Conference Paper

References (24)

1. Yu H Jove R The STATs of cancer - new molecular targets come of age Nat Rev Cancer 2004, 4(2):97-105. 10.1038/nrc1275 14964307
2. James C Ugo V Le Couedic JP Staerk J Delhommeau F Lacout C Garcon L Raslova H Berger R Bennaceur-Griscelli A et al.: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 2005, 434(7037):1144-1148. 10.1038/nature03546 15793561
3. Baxter EJ Scott LM Campbell PJ East C Fourouclas N Swanton S Vassiliou GS Bench AJ Boyd EM Curtin N et al.: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 2005, 365(9464):1054-1061. 15781101
4. Levine RL Pardanani A Tefferi A Gilliland DG Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders Nat Rev Cancer 2007, 7(9):673-683. 10.1038/nrc2210 17721432
5. Vannucchi AM Antonioli E Guglielmelli P Rambaldi A Barosi G Marchioli R Marfisi RM Finazzi G Guerini V Fabris F et al.: Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia Blood 2007, 110(3):840-846. 10.1182/ blood-2006-12-064287 17379742
6. Shudo E Yang J Yoshimura A Iwasa Y Robustness of the signal transduction system of the mammalian JAK/STAT pathway and dimerization steps J Theor Biol 2007, 246(1):1-9. 10.1016/j.jtbi.2006.11.016 17241643
7. Yamada S Shiono S Joo A Yoshimura A Control mechanism of JAK/STAT signal transduction pathway FEBS Lett 2003, 534(1-3):190-196. 10.1016/ S0014-5793(02)03842-5 12527385
8. Papin JA Palsson BO The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis Biophysical Journal 2004, 87(1):37-46. 1304358 15240442 10.1529/biophysj.103.029884
9. Zi Z Cho KH Sung MH Xia X Zheng J Sun Z In silico identification of the key components and steps in IFN-gamma induced JAK-STAT signaling pathway FEBS Lett 2005, 579(5):1101-1108. 10.1016/j.febslet.2005.01.009 15710397
10. Soebiyanto RP Sreenath SN Qu CK Loparo KA Bunting KD Complex systems biology approach to understanding coordination of JAK-STAT signaling Biosystems 2007, 90(3):830-842. 2128044 17646048 10.1016/ j.biosystems.2007.05.005
11. Hookham MB Elliott J Suessmuth Y Staerk J Ward AC Vainchenker W Percy MJ McMullin MF Constantinescu SN Johnston JA The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3 Blood 2007, 109(11):4924-4929. 10.1182/blood-2006-08-039735 17317861
12. Hammond E Shaw K Carnley B P'ng S James I Herrmann R Quantitative determination of JAK2 V617F by TaqMan: An absolute measure of averaged copies per cell that may be associated with the different types of myeloproliferative disorders J Mol Diagn 2007, 9(2):242-248. 1867447 17384217 10.2353/jmoldx.2007.060125
13. Tiedt R Hao-Shen H Sobas MA Looser R Dirnhofer S Schwaller J Skoda RC Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice Blood 2008, 111(8):3931-3940. 10.1182/ blood-2007-08-107748 18160670
14. Ishii T Zhao Y Shi J Sozer S Hoffman R Xu M T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation Leukemia 2007, 21(12):2433-2441. 10.1038/sj.leu.2404899 17713553
15. Shimamoto T Ohyashiki K Ohyashiki JH Kawakubo K Fujimura T Iwama H Nakazawa S Toyama K The expression pattern of erythrocyte/ megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia Blood 1995, 86(8):3173-3180. 7579412
16. Persons DA Allay JA Allay ER Ashmun RA Orlic D Jane SM Cunningham JM Nienhuis AW Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis Blood 1999, 93(2):488-499. 9885210
17. Gombart AF Kwok SH Anderson KL Yamaguchi Y Torbett BE Koeffler HP Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1 Blood 2003, 101(8):3265-3273. 10.1182/blood-2002-04-1039 12515729
18. Hart A Melet F Grossfeld P Chien K Jones C Tunnacliffe A Favier R Bernstein A Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia Immunity 2000, 13(2):167-177. 10.1016/ S1074-7613(00)00017-0 10981960
19. Huang LJ Constantinescu SN Lodish HF The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor Mol Cell 2001, 8(6):1327-1338. 10.1016/ S1097-2765(01)00401-4 11779507
20. Lu X Levine R Tong W Wernig G Pikman Y Zarnegar S Gilliland DG Lodish H Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation Proc Natl Acad Sci USA 2005, 102(52):18962-18967. 1323216 16365288 10.1073/pnas.0509714102
21. Schmidt H Jirstrand M Systems Biology Toolbox for MATLAB: A computational platform for research in systems biology Bioinformatics (Oxford, England) 2006, 22(4):514-515. 10.1093/bioinformatics/bti799 16317076
22. Walrafen P Verdier F Kadri Z Chretien S Lacombe C Mayeux P Both proteasomes and lysosomes degrade the activated erythropoietin receptor Blood 2005, 105(2):600-608. 10.1182/blood-2004-03-1216 15358619
23. Dahlen DD Broudy VC Drachman JG Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs Blood 2003, 102(1):102-108. 10.1182/blood-2002-11-3468 12623841
24. Tong W Sulahian R Gross AW Hendon N Lodish HF Huang LJ The membrane-proximal region of the thrombopoietin receptor confers its high surface expression by JAK2-dependent and -independent mechanisms J Biol Chem 2006, 281(50):38930-38940. 10.1074/jbc.M607524200 17052978